medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 4

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2012; 50 (4)

Idiopathic hepatic angiosarcoma. Case report

Granados-López SL, Gómez-Jiménez LM, Chávez-Bravo NC, Sánchez-Rodríguez C
Full text How to cite this article

Language: Spanish
References: 14
Page: 445-448
PDF size: 117.08 Kb.


Key words:

Hemangiosarcoma, liver neoplasms, hemoperitoneum.

ABSTRACT

Hepatic angiosarcoma is a malignant mesenchymal neoplasm of endothelial cells of high grade. Hepatic angiosarcoma represents two percent of all primary neoplasm liver. The highest incidence is between the sixth and seventh decade of life, youth and children is rare, predominantly in men (3:1). Most are idiopathic (75 %). Diagnosis is difficult because clinical manifestations and imaging studies are inconclusive. When clinical manifestations begin progression is often fast, and possibilities for curative treatment are limited. We report the case of a man aged 17, presented two clinical episodes of hemoperitoneum with ultrasound and CT diagnosis of hepatic hemangioma, hepatectomy was performed in the right lobe, the histological study reported multicenter liver angiosarcoma.


REFERENCES

  1. Ishak KG, Goodman ZD, Stocker JT. Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts. Third series. Washington, DC: Armed Forces Institute of Pathology; 1999. Fascicle 31.

  2. Molina E, Hernández A. Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci 2003;48(4):677- 682.

  3. Valenzuela J, Poveda MG. Angiosarcoma hepático. presentación de dos casos. Rev Esp Enferm Dig 2009;101 (6):430-437.

  4. Tannapfel A, Weihrauch M, Benicke M, Uhlmann D, Hauss J, Wrbitzky R, et al. p16INK4A-alterations in primary angiosarcoma of the liver. J Hepatol 2001;35(1):62-67.

  5. Bhati CS, Bhatt AN, Starkey G, Hubscher SG, Bramhall SR. Acute liver failure due to primary angiosarcoma: a case report and review of literature. World J Surg Oncol 2008;6:104. Disponible en http://www.wjso.com/content/ 6/1/104

  6. Rademaker J, Widjaja A, Galanski M. Hepatic hemangiosarcoma: imaging findings and differential diagnosis. Eur Radiol 2000;10(1):129-133.

  7. Koyama T, Fletcher JG, Johnson CD, Kuo MS, Notohara K, Burgart LJ. Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology 2002;222(3):667-673. Disponible en http://radiology.rsna.org/cgi/pmidlookup?view =long &pmid=11867783

  8. Quiang L, Xishan H. Hepatic angiosarcoma: a review of twelve cases. Chin J Clin Oncol 2005;2(1):457-462.

  9. Seung-Woo Lee, Chun-Young Song, Young-Hwa Gi, Sang- Beom Kang, Yon-Soo Kim, Soon-Woo Nam, et al. Hepatic angiosarcoma manifested as recurrent hemoperitoneum. World J Gastroenterol 2008;14(18):2935-2938.

  10. Odze R. Surgical of pathology of the GI tract, liver, biliary tract and pancreas. Segunda edición. Philadephia: Saunders; 2009.

  11. Matthaei H, Boelke E, Eisenberger CF, Alldinger I, Krieg A, Schmelzle M, et al. Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgery. Eur J Med Res 2007;12(12): 591-594.

  12. Kim HR, Rha SY, Cheon SH, Roh JK, Park YN, Yoo NC. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma. Ann Oncol 2009;20 (4):780-787. Disponible en http://annonc.oxfordjournals. org/content/20/4/780.long

  13. Matthaei H, Krieg A, Schmelzle M, Boelke E, Poremba C, Rogiers X, et al. Long-term survival after surgery for primary hepatic sarcoma in adults. Arch Surg 2009;144 (4):339-344.

  14. Stambo GW, Guiney MJ. Hepatic angiosarcoma presenting as an acute intraabdominal hemorrhage treated with transarterial chemoembolization. Sarcoma 2007:1-4. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225 468/?tool=pubmed




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2012;50